The leading life sciences reagents and instruments company is expected to announce its fiscal second-quarter earnings for ...

Bio-Techne TECH reported third-quarter fiscal 2025 adjusted earnings per share (EPS) of 56 cents, which surpassed the Zacks Consensus Estimate by 9.8%. The bottom line improved from the year-ago ...

Bio-Techne Corporation TECH is set to release fourth-quarter fiscal 2025 results on Aug. 6, before the opening bell. The life science and diagnostic product maker posted adjusted earnings per share ...

Bio-Techne (NASDAQ:TECH) will release its quarterly earnings report on Wednesday, 2025-11-05. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Bio-Techne to report ...

Bio-Techne (TECH) is back in focus after a recent analyst downgrade that cited softer organic growth and a weaker free cash ...

--Bio-Techne Corporation today reported its financial results for the third quarter ending March 31, 2025. Delivered adjusted EPS of $0.56 compared to $0.48 one year ago. Improved pharma end market ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Bio-Techne reported fiscal third-quarter organic revenue growth of 6% year on year, consisting of 7% organic growth in protein sciences and 2% in diagnostics and spatial biology. Adjusted operating ...

--Bio-Techne Corporation today reported its financial results for the fourth quarter ending June 30, 2025. Full year adjusted EPS was $1.92 versus $1.77 one year ago. Strong performance in our ...

Bio-Techne Corporation TECH is set to release first-quarter fiscal 2026 results on Nov. 5, before the opening bell. The life science and diagnostic product maker posted adjusted earnings per share ...